Learn More
Medchemexpress LLC Act-462206 | 1361321-96-1 | MFCD28502270 | 99.5% | 388.48 | C20H24N2O4S | 25 MG

Supplier: Medchemexpress LLC HY10183425MG
ACT-462206 is an orally active, brain-penetrant dual orexin (OX1/OX2) receptor antagonist used in neuroscience research into sleep, anxiety, and addiction. The compound shows low-nanomolar activity at orexin receptors and is supplied as a high-purity solid or solution format for laboratory use (research use only).
- Dual orexin receptor antagonist with low-nanomolar potency (OX1 and OX2)
- Brain-penetrant properties suitable for CNS pharmacology studies
- High purity (~99.5%) for reliable biochemical and pharmacological testing
- Soluble in DMSO at ≥100 mg/mL for in vitro preparations
- Available in research-scale solid and solution formats
- Stored and shipped under recommended conditions to preserve stability
- For research use only, not for human or clinical use
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.